Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06615401 · ClinicalTrials.gov registry record
Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 986
- Enrollment target
NCT06615401: Completed study, sponsored by VA Office of Research and Development.
NCT06615401 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 986 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06615401 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 986 participants
- Enrollment target
Study Summary
Transgender Veterans (trans Vets) frequently experience gender dysphoria or distress related to discord between their gender identity and birth sex. Gender-affirming treatments (GATs) are medically necessary treatments to reduce gender dysphoria. However, not much is known about the barriers and facilitators that influence GAT access and receipt in VA and VA Community Care (CC), among trans Vets who desire GATs. The goals of this mixed-methods study are to determine which GATs trans Vets receive and in which setting, identify barriers and facilitators associated with desired GAT receipt in VA and CC, examine association of GAT receipt, specifically mental healthcare and hormone therapy, with mental health and suicide risk and understand trans Vet experiences related to receipt and desire for mental healthcare and hormone therapy in VA and CC.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 986 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2025-01-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06615401
The ClinicalTrials.gov registry entry for NCT06615401 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 986 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06615401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06615401 about?
NCT06615401 is a clinical study titled "Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans". Transgender Veterans (trans Vets) frequently experience gender dysphoria or distress related to discord between their gender identity and birth sex. Gender-affirming treatments (GATs) are medically necessary treatments to reduce gender dysphoria. However, not much is known about the barriers and fac...
What is the current status of trial NCT06615401?
This trial is currently completed. The enrollment target is 986 participants. The study started on 2024-10-01. Estimated completion is 2025-01-18.
Who is sponsoring clinical trial NCT06615401?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.